Table 4 Intradermal vs intratumoral and intradermal administration comparisons
Case | DTH reaction to tumour lysate | ELISPOT assay | Radiological findings |
|---|---|---|---|
Intradermal administration | Â | Â | Â |
1 | − | ND | NC |
7 | ND | − | PD |
8 | + | + | NC |
9 | ND | − | PD |
10 | − | ND | PD |
Intratumoral and Intradermal administration | Â | Â | Â |
2 | ND | ND | NC |
3 | + | − | MR |
4 | ND | ND | NC |
5 | − | ND | PD |
6 | + | + | MR |
+=positive; −=negative; ND=not tested; MR=minor response; NC=no change; PD=progressive disease. | |||
